Collegium Pharmaceutical Inc (NASDAQ: COLL) stock closed at $31.50 on 5/10/24 after a major decline of -16.8%. Moreover, this decline was accompanied by exceptionally high trading volume at 522% of normal. The stock has declined -16.0% during the last week but has been exceptionally strong relative to the market over the last nine months.
Current PriceTarget Research Rating
COLL is expected to continue to be a major Value Builder reflecting capital returns that are forecasted to be above the cost of capital.
Collegium Pharmaceutical has a current Value Trend Rating of A (Highest Rating). The Value Trend Rating reflects highly consistent signals from PTR’s two proprietary measures of a stock’s attractiveness. Collegium Pharmaceutical has a very high Appreciation Score of 95 and a very high Power Rating of 96, resulting in the Highest Value Trend Rating.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of A. This review will be completed in the next several days.
Be the first to comment